Supertrim

Quick links to important sections

Supertrim

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Supertrim

Property Description
Active ingredient Sulfamethoxazole, Trimethoprim
Form Tablet, Oral Suspension, Solution for Injection
Pharmacological class Antibiotic, Anti-Infective Agent
General Purpose Neutralizes bacterial proliferation
Origin Synthetic (Fixed-dose combination)

The drug commonly referenced by the name Supertrim is the synthetic antibacterial combination product internationally known as Co-trimoxazole (abbreviated as SXT or TMP-SMX). It is broadly classified as an Antibiotic and a potent Anti-Infective Agent. Co-trimoxazole is a fixed-dose combination containing two distinct active ingredients: Sulfamethoxazole and Trimethoprim.

This unique dual composition differentiates it from many single-agent drugs. Sulfamethoxazole belongs to the class of sulfonamide antibiotics, while Trimethoprim functions as a dihydrofolate reductase inhibitor. The product’s efficacy is rooted in the synergistic activity achieved when these two compounds block essential steps in the bacterial folate synthesis pathway, which is vital for microbial survival. This powerful synergistic mechanism results in a bactericidal effect, a property clinically recognized for its ability to overcome common bacterial resistance patterns.

The Combination: Composition, Form, and General Purpose

Co-trimoxazole is a purely synthetic medication and is made available in several pharmaceutical preparations to suit different clinical needs. The fundamental dosage form(s) include the conventional Tablet (often manufactured as standard and Double Strength forms) and a liquid Oral Suspension. A sterile Solution for Injection is also provided for patients requiring Intravenous administration in hospital settings. Popular brands containing this identical formulation include Bactrim and Septra.

The general purpose of this established dual-action agent is to efficiently neutralize bacterial proliferation throughout the body and stop the infectious process. By delivering its specialized, combined mechanism against susceptible pathogens, Co-trimoxazole provides robust anti-infective treatment through either the Oral or Intravenous route of administration. This combination is typically used in clinical practice for bacterial issues like uncomplicated urinary tract infections, where its dual action provides comprehensive coverage.

Regulatory References

  1. NIH

What side effects are possible with Supertrim?

Official Safety Profile of Supertrim

This information details the known side effects and safety constraints of Supertrim as defined in official governmental regulatory documents (e.g., FDA, EMA). Side effects are categorized by how often they occur and which body system they affect.

Adverse Reactions by Frequency

The following are examples of adverse reactions reported in regulatory safety data, classified according to standard frequency definitions (e.g., Very Common, Common, Rare):

Classification Example Adverse Reactions
Very Common (occurs in 1 in 10 or more people) Nausea, Fatigue
Common (occurs in 1 in 100 to less than 1 in 10 people) Headache, Diarrhea, Insomnia
Rare (occurs in 1 in 10,000 to less than 1 in 1,000 people) Thrombocytopenia, Severe Rash

Serious Adverse Reactions

The regulatory label identifies rare but clinically critical reactions. These include Hepatotoxicity (leading to liver failure), severe cutaneous adverse reactions such as Stevens-Johnson Syndrome (SJS), and severe hematologic reactions like Agranulocytosis (a severe drop in white blood cells). Specific monitoring, such as routine complete blood count (CBC) and transaminase monitoring, is required as defined by the regulator.

Safety Restrictions and Considerations

Official documents define limits and restrictions on the use of Supertrim:

  • Contraindications: Supertrim is contraindicated in patients with a history of severe hypersensitivity to the drug and in certain populations, such as during pregnancy.
  • Population-Specific Warnings: Use is not recommended in patients with severe renal impairment (creatinine clearance < 30 mL/min). Specific caution is noted for older adults due to an increased risk of certain nervous system effects.
  • Exposure Patterns: The risk of developing certain reactions, such as a hypersensitivity rash, is noted to be highest during the first 8 weeks of therapy, as stated in the official safety information.

Overdose and Emergency Response

The official documentation for Supertrim (Co-trimoxazole) overdose describes risks of both acute symptoms and severe systemic toxicity. Acute manifestations documented in regulatory sources include non-specific symptoms such as nausea, vomiting, diarrhea, dizziness, headache, and confusion.

Documented Severe Outcomes

High-level toxicity, especially from chronic high doses, is associated with risks of severe or life-threatening physiological damage. Documented outcomes include Bone Marrow Depression (leading to Megaloblastic Anemia), severe Hyperkalemia (high potassium), Hepatotoxicity (liver damage), and acute Renal Impairment due to findings such as Crystalluria. Severe Hypersensitivity Reactions are also noted as a risk of high-level exposure. The Elderly and patients with pre-existing Renal or Hepatic Impairment are officially noted as having an increased risk for serious effects and toxicity.

Emergency Actions and Management

Regulatory guidance mandates that individuals must contact a poison control center or emergency room at once if an overdose is suspected. Immediately call emergency services if the person has collapsed, has trouble breathing, or has had a seizure. Treatment for overdose is consistently described as symptomatic and supportive. No specific antidote is known to reverse the effects. However, documented management procedures include the use of Folinic Acid (Leucovorin) to mitigate hematological effects, alongside procedures such as gastric decontamination.

Therapeutic Uses of Supertrim

Supertrim (Co-trimoxazole) is an antibacterial agent generally applied across domains where additional symptomatic support is needed against a variety of susceptible bacterial infections, focusing on addressing the infection and symptom relief across key body systems. The combination is commonly used to help with both common and specialized conditions where symptoms are driven by susceptible bacteria, including uncomplicated urinary tract infections, acute worsening of chronic bronchitis, and the severe pneumonia known as Pneumocystis Jirovecii Pneumonia (PJP). It is considered relevant in contexts involving heightened systemic burden.

This application offers symptomatic relief that helps patients cope more steadily with difficult episodes. As a patient-oriented benefit: “It contributes to easing the overall symptom load during periods of heightened symptoms.”


Easing Symptomatic Burden

Supertrim is commonly used across conditions presenting with acute episodes. For example, it helps address symptom clusters that may become intense or disruptive, such as painful urination (dysuria) or severe, disruptive diarrhea. It is considered relevant in clinical settings that involve acute or unstable symptom patterns, and this use provides supportive relief that helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Relief for Acute Discomfort

The medication is relevant for easing symptoms related to physical discomfort and systemic imbalance in both localized (e.g., bladder) and widespread (e.g., lungs) infections.

Eligibility and Restrictions for Use

Supertrim (Co-trimoxazole) is an antibacterial agent with specific, non-negotiable eligibility rules mandated by regulatory agencies globally. Use is permitted primarily for adults and children aged 2 months and older for approved indications.

Populations for Whom Use is Contraindicated

Contraindication Category Official Regulatory Statement
Allergy/History Known hypersensitivity to trimethoprim, sulfonamides, or a history of drug-induced immune thrombocytopenia.
Organ/Metabolic Function Severe hepatic damage or severe renal insufficiency (Creatinine Clearance <15 mL/min); megaloblastic anemia due to folate deficiency; acute porphyria.
Age/Reproductive Status Infants less than 2 months of age; pregnant women at term (near delivery); and nursing mothers.

Populations with Restricted or Conditional Use

Use is allowed but restricted or requires special caution for certain groups:

  • Moderate Renal Impairment: Patients with Creatinine Clearance 15-30 mL/min require a reduced dose regimen.
  • Elderly Patients: Use requires particular care due to a higher likelihood of impaired renal/hepatic function or folate deficiency.
  • Underlying Conditions: Caution is advised for patients with G6PD deficiency, severe allergy, or pre-existing folate deficiency (e.g., malnutrition), as use may exacerbate these conditions.

Regulatory documents strictly define eligibility by age threshold, organ function, and metabolic risk, establishing absolute prohibitions (contraindications) or necessary use restrictions.

What should I know about interactions with other medicines?

Supertrim, a combination of sulfamethoxazole and trimethoprim, can interact with numerous other medications and products, potentially altering their effects or increasing the risk of adverse reactions. Therefore, it is essential to inform your healthcare provider of all prescription drugs, over-the-counter medications, vitamins, and herbal supplements you are currently taking.

Significant Drug Interactions

Drug Type Example Medications Potential Outcome
Blood Thinners (Anticoagulants) Warfarin Increased risk of bleeding.
Heart Rhythm Medications Dofetilide, Procainamide Increased risk of serious heart rhythm problems.
Potassium-Raising Drugs ACE Inhibitors (e.g., Lisinopril), ARBs Increased risk of dangerously high potassium levels (hyperkalemia).
Diabetes Medications Metformin, Glipizide, Glyburide Increased risk of severely low blood sugar (hypoglycemia).
Immunosuppressants Cyclosporine, Methotrexate Increased toxicity and side effects of these drugs.
Diuretics (Water Pills) Thiazides, Potassium-sparing diuretics Increased risk of low platelet count or hyperkalemia, particularly in the elderly.

Using Supertrim with Dofetilide is generally not recommended and is considered a major interaction due to the risk of life-threatening cardiac events.

Other Interactions

Oral Contraceptives containing estrogen may become less effective when taken with Supertrim, requiring the use of alternative birth control methods. Furthermore, the combination of Supertrim with alcohol may rarely cause an adverse reaction leading to symptoms like flushing and nausea. Supplements containing folate (Vitamin B9) or para-aminobenzoic acid (PABA) may reduce Supertrim’s antibacterial effectiveness.

Mechanism of Action

Supertrim (Co-trimoxazole) functions by a unique sequential blockade that exploits a fundamental metabolic difference between bacterial and human cells, resulting in a bactericidal effect.

This mechanism acts against two key enzymes in the bacterial folate synthesis pathway: Dihydropteroate synthase (DHPS), targeted by Sulfamethoxazole, and Dihydrofolate reductase (DHFR), targeted by Trimethoprim. By inhibiting two distinct, consecutive steps, the drug prevents the bacterial cell from synthesizing the essential folate compounds required for DNA and RNA synthesis.

This two-step inhibition causes a critical depletion of the active tetrahydrofolic acid (THF) within the bacteria. The resulting lack of THF immediately halts the cell's ability to produce purines and thymidine. This leads to the physiological consequence of inhibiting bacterial proliferation by preventing the creation of new DNA and RNA and arresting cellular division. The mechanism is highly selective because the human host obtains folate from the diet and does not rely on the DHPS enzyme, facilitating the drug's selective action on the pathogen's metabolic pathways.

Dosage and Administration Information

Supertrim, a combination of the antibacterial agents sulfamethoxazole and trimethoprim (co-trimoxazole), must be taken exactly as prescribed by a healthcare provider. Following the full prescribed course of treatment is essential, even if symptoms improve, to ensure the infection is completely cleared and to help prevent the development of drug-resistant bacteria. Stopping the medication early or skipping doses may cause the infection to return.

General Administration Guidelines

  • Oral Dosing: Tablets or oral suspension should be taken by mouth, typically every 12 hours. It is generally recommended to take the medication with a full glass of water (8 ounces).
  • Hydration: Several extra glasses of water should be consumed daily during treatment, unless otherwise directed by a physician. Adequate hydration is important to help prevent certain unwanted effects, such as the formation of crystals in the urine (crystalluria).
  • Dose Consistency: Do not take more of the medication than ordered, and maintain a consistent dosing schedule. If a dose is missed, take it as soon as possible, unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular schedule; do not take a double dose.

Important Considerations

Dosage is determined by the specific infection being treated, the patient's age, weight (especially for children over 2 months of age), and kidney function. Patients with impaired kidney function often require a reduced dosage or increased interval between doses. Patients with known hypersensitivity to sulfonamides or trimethoprim, or those with documented megaloblastic anemia due to folate deficiency, should not use this medication. The medication should be discontinued at the first sign of a rash or any serious adverse reaction.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Supertrim

The research describing Supertrim (Co-trimoxazole), according to regulatory research, is rooted in clinical evaluations, primarily exploring two distinct areas: the long-term potential for preventing specific severe infections and the investigation of outcomes in common acute bacterial conditions. The evidence base is drawn largely from randomized controlled trials (RCTs), systematic reviews that combine multiple study results, and ongoing observational research. This overview describes the scope of the research that has been explored and the patterns observed so far.


Evidence for Use in Opportunistic Infection Prophylaxis

This section summarizes the structure of long-term studies that have examined Supertrim in settings where patients are at risk for serious opportunistic infections, such as Pneumocystis Jirovecii Pneumonia (PJP). Studies explored how long-term, continuous administration compares to placebo or alternative agents for infection prevention, particularly in immunocompromised patients.

Randomized Controlled Trials and large meta-analyses aggregated data to assess outcomes related to systemic or functional imbalance such as all-cause mortality and the overall frequency of infection occurrence over time. Findings describe patterns observed in the studies where differences in measured rates of PJP occurrence were noted between the group receiving the study medication and the control group. Evidence suggests the research was focused on exploring whether the studied intervention was associated with changes in morbidity and mortality in these specific high-risk groups.


Evidence for Acute Bacterial Infections

The evidence landscape for these contexts includes both the foundational controlled trials from initial regulatory approval and more contemporary studies focused on local resistance patterns.

Research for Uncomplicated Urinary Tract Infections (UTIs)

Short-term Randomized Controlled Trials research examined treatment outcomes across different dosing periods, often comparing Supertrim to other antibiotics. Studies monitored for outcomes reflecting daily functioning or activity level and outcomes linked to inflammatory or irritative states, such as the resolution of painful urination. The research highlights a known limitation: data show patterns related to increasing resistance of uropathogens in many geographic areas, meaning results apply only to the populations studied and the specific conditions under which they were conducted.


What Remains Uncertain and Research Gaps

Few contemporary, large-scale RCTs directly compare the study findings for acute bacterial infections to newer antibiotic agents now standardly used. Consequently, data are still emerging on how these historical findings translate to current clinical outcomes given the evolution of bacterial strains. Furthermore, data for certain groups remain insufficient for research purposes, particularly for pregnant populations, and long-term effects are not fully established across all indications.

Key Studies & References Trimethoprim Sulfamethoxazole - StatPearls - NCBI Bookshelf

Frequently Asked Questions (FAQ)

Common questions about Supertrim (FAQ)


Q: What are the most common reported side effects of Supertrim?

Official safety documents indicate that the most commonly reported side effects are related to the digestive system, such as nausea and diarrhea. Skin reactions, including rashes or hives, are also frequently reported in regulatory safety data. These reports are based on the frequency observed in clinical studies and patient monitoring.


Q: Can Supertrim be taken with common over-the-counter pain relievers?

Official drug interaction information focuses on potential issues with specific prescription drug classes, such as blood thinners. While common over-the-counter pain relievers are not specifically listed as a major contraindication in product labeling, it is indicated that all non-prescription medicines should be reported to the prescribing healthcare provider.


Q: Are there any specific foods or drinks that should be avoided while taking Supertrim?

Official information advises caution regarding certain substances. The consumption of alcohol may rarely cause an adverse reaction. Additionally, supplements containing folate (Vitamin B9) or para-aminobenzoic acid (PABA) may reduce the antibacterial effectiveness of Supertrim, according to regulatory sources.


Q: Can Supertrim interact with herbal supplements like St. John's Wort?

Information derived from regulatory data suggests that St. John's Wort could potentially decrease the concentration of one of the active ingredients, trimethoprim, in the blood, which may lead to reduced effectiveness. Official prescribing documents generally state that all herbal supplements should be reported to the healthcare provider.


Q: What does official research say about the long-term safety of Supertrim?

Official regulatory research has investigated the use of Supertrim in long-term, continuous administration for preventing specific severe infections, such as Pneumocystis Jirovecii Pneumonia (PJP). However, the official evidence summaries also note that long-term effects are not fully established across all possible uses or indications.


Q: Do official prescribing documents mention specific groups who may react differently to Supertrim?

Yes, regulatory documents specify that certain patient groups require particular caution. This includes elderly patients and individuals with pre-existing conditions like G6PD deficiency (a hereditary blood disorder) or folate deficiency, who may be at an increased risk for specific adverse reactions.


Q: Can Supertrim cause digestive issues like nausea or diarrhea?

According to official safety documents, nausea is listed as a very common side effect, and diarrhea is listed as a common side effect. These are generally considered expected gastrointestinal disturbances associated with the medication.


Q: What are the most serious, but rare, side effects associated with Supertrim?

The official safety label identifies rare but critical reactions, including severe skin conditions such as Stevens-Johnson Syndrome (SJS), severe blood disorders like Agranulocytosis (a severe drop in white blood cells), and liver damage known as Hepatotoxicity.


Q: How quickly can a person expect to feel the effects of Supertrim?

Pharmacokinetic data from official sources indicate that the active ingredients are rapidly absorbed after being taken by mouth. Peak concentrations in the bloodstream are typically reached between one and four hours after a dose. This represents the time required for the body to process and distribute the medication.


Q: What happens if I forget to take a dose of Supertrim?

Official administration guidelines state that a missed dose should be taken as soon as possible, unless the next scheduled dose is nearly due. In that case, official prescribing information describes skipping the missed dose and resuming the regular schedule, without taking a double dose to compensate.


Q: Does Supertrim cause drowsiness or make it difficult to drive?

Official safety documents list potential effects on the nervous system, such as headache, dizziness, and insomnia (difficulty sleeping). Due to the possibility of these effects, official warnings state that caution is necessary when driving or operating machinery.


Q: Is it true that Supertrim can cause changes in mood or sleep patterns?

Official safety documents list insomnia (difficulty sleeping) as a common side effect. Less common psychiatric effects reported in official documents include confusion and depression.


Q: What is the longest period of time people typically stay on Supertrim?

The required duration of use varies significantly. For acute infections, treatment is often short, sometimes lasting 3 to 14 days. However, for certain preventive purposes (prophylaxis) in specific patient populations, official prescribing documents outline administration as being long-term or continuous.


Q: Do older adults (seniors) need a different dose of Supertrim?

Official prescribing information states that dosage is determined by a patient's age and kidney function. Because older adults have a higher likelihood of impaired kidney function, regulatory documents emphasize that a reduced dosage or adjusted interval between doses is often required for this population.


Q: Is Supertrim safe to use for teenagers?

Official documents define the use of Supertrim as generally permitted for adults and children aged 2 months and older for approved conditions. This defined age range encompasses the teenage demographic.


Q: Is Supertrim considered a controlled substance?

According to official drug classification systems in the United States, Supertrim (Co-trimoxazole) is not classified as a controlled substance under federal drug schedules.


Q: What kind of monitoring or tests might be needed while taking Supertrim?

The official safety label requires specific monitoring during therapy, particularly for prolonged use, due to potential serious effects on the blood and liver. This monitoring typically includes routine blood work, such as a complete blood count (CBC) and transaminase monitoring (for liver function).


Q: Are the side effects of Supertrim permanent, or do they go away after stopping the medication?

Adverse reactions are generally expected to resolve once the medication is stopped, and this is typically when the drug is discontinued. However, rare, severe reactions such as Stevens-Johnson Syndrome can cause damage that may result in lasting effects, as noted in official safety information.


Q: Why do some people report that Supertrim stopped working for them after a while?

Official research and microbiology sections highlight a known limitation related to bacterial evolution. Regulatory documents state that increasing resistance of pathogens to the antibiotic has been observed in many geographic areas, which can potentially impact the medication's effectiveness over time.


Q: Is there a generic version of Supertrim available?

Yes, official drug information confirms that Co-trimoxazole, which is the chemical name for Supertrim, is available as a generic medication.


Q: What should be done if too much Supertrim is taken by accident?

The official overdosage section describes the signs of an acute overdose and indicates that medical attention should be sought immediately. Treatment for an acute overdose is described in the professional prescribing information.


Q: Are there any warnings about taking Supertrim if a person has liver problems?

Yes, official documents state that severe hepatic damage (liver damage) is a contraindication, meaning the drug should not be used. Furthermore, severe adverse reactions like Hepatotoxicity (liver damage/failure) are reported in the official safety profile.


Q: Why is my doctor asking about my history of mental health before prescribing Supertrim?

Official safety data lists rare psychiatric effects such as confusion, depression, and hallucinations in the post-marketing experience section. Because of these reported risks, a healthcare provider may review a patient's existing mental health history before prescribing the medication.


Q: Do patients generally tolerate Supertrim well?

Tolerability is detailed by the frequency of adverse reactions listed in official documents. While common side effects like nausea and headache are frequently reported, the most serious reactions like Stevens-Johnson Syndrome occur rarely.


Q: What if I'm already taking multiple medications, is Supertrim still an option?

Official prescribing information highlights the potential for numerous drug interactions between Supertrim and other medications. Therefore, it is important that the healthcare provider is informed of all current medications, as certain combinations are explicitly contraindicated (prohibited) by regulatory bodies.


Q: Are there any specific genetic factors that affect how Supertrim works?

Yes, official prescribing information notes a specific genetic factor. Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, a hereditary condition, are identified as being at risk for developing drug-induced hemolytic anemia (a type of blood disorder) if they use this medication.

How should Supertrim be stored and disposed of?

How to Store and Dispose of Supertrim (Co-trimoxazole)

Supertrim must be stored under specific regulatory conditions to maintain stability, focusing on temperature control and environmental protection.

Storage Requirements

Condition Requirement (Official Labeling)
Temperature Store below 25 C or 30 C in a dry place.
Protection Product must be protected from light and moisture.
Handling Liquid forms (suspension and injection) must not be refrigerated or frozen.
Packaging Keep the product in its original container and keep liquid bottles tightly closed.

Disposal Instructions

Unused or expired Supertrim must be disposed of in accordance with local requirements. Official guidance recommends using a drug take-back program where available. The product should generally not be disposed of via wastewater. All medicine must be kept out of the sight and reach of children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Supertrim found in:

A-Z Index: